BioCryst Pharmaceuticals reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
BioCryst Pharmaceuticals 0 0 Mar/2025
Chugai Pharma 1.62 0.2 Jun/2026
Daiichi Sankyo 2.79 0.2 Sep/2026
DBV Technologies USD 0 0 Aug/2024
Enanta Pharmaceuticals 0 0 Mar/2025
Gilead Sciences 2.18 0.37 Sep/2026
GlaxoSmithKline 2.78 1.93 Sep/2026
Glaxosmithkline GBP 1.88 2.59 Sep/2026
Karyopharm Therapeutics 0 0 Mar/2025
Regeneron Pharmaceuticals 0.58 0.12 Jun/2026
Roche Holding 2.94 0.01 Jun/2026